Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence of Colorectal Advanced Adenomas
ChiCTR2600128330Phase 3Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon adenoma comparing Jianpi Lishi Jiedu Granules with Placebo granules (2 arms). Primary endpoint: recurrence rate of colorectal advanced adenomas. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Jianpi Lishi Jiedu Granules
03
Conditions
colon adenoma
Beyond the preview
Go deeper on ChiCTR2600128330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128330.